Yayın:
A Different Perspective on the Characterization of a New Degradation Product of Flibanserin With HPLC–DAD–ESI-IT-TOF-MSn and Its Pharmaceutical Formulation Analysis With Inter-Laboratory Comparison

Sadeleştirilmiş öğe sayfası
dc.contributor.authorGeven, Aysun
dc.contributor.authorÖZCAN, SANİYE
dc.contributor.authorLEVENT, SERKAN
dc.contributor.authorCAN, NAFİZ ÖNCÜ
dc.contributor.orcid0000-0001-5436-7519
dc.contributor.orcid0000-0002-5492-0457
dc.contributor.orcid0000-0003-3692-163X
dc.contributor.orcid0000-0003-0280-518X
dc.date.accessioned2025-11-13T18:51:23Z
dc.date.issued2023-06-22
dc.identifier.doihttps://doi.org/10.1093/jaoacint/qsad074
dc.identifier.endpage1153
dc.identifier.issn1060-3271
dc.identifier.issue5
dc.identifier.openalexW4381611125
dc.identifier.startpage1145
dc.identifier.urihttps://hdl.handle.net/11421/10843
dc.identifier.urihttps://doi.org/10.1093/jaoacint/qsad074
dc.identifier.volume106
dc.language.isoen
dc.relation.ispartofJournal of AOAC International
dc.rightsopenAccess
dc.subjectChemistry
dc.subjectChromatography
dc.subjectHigh-performance liquid chromatography
dc.subjectAmmonium acetate
dc.subjectForced degradation
dc.subjectDegradation (telecommunications)
dc.subjectAcetonitrile
dc.subject.sdg3
dc.titleA Different Perspective on the Characterization of a New Degradation Product of Flibanserin With HPLC–DAD–ESI-IT-TOF-MSn and Its Pharmaceutical Formulation Analysis With Inter-Laboratory Comparison
dc.typeArticle
dspace.entity.typePublication
local.authorid.openalexA5012333467
local.authorid.openalexA5067792682
local.authorid.openalexA5075534569
local.authorid.openalexA5001553522

Dosyalar

Koleksiyonlar

Publications